Response Genetics, Inc. (NASDAQ:RGDX)
CAPS Rating:
The Company is engaged in the research and development of its own pharmacogenomic cancer diagnostic tests based on its proprietary technologies.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| CRAZYCAPTAIN | 98.43 | 6/12/2007 |
|
3Y | $7.13 | -76.16% | -7.09% | -69.07 | 1 Comment | |
| JumperLee | < 20 | 6/6/2007 |
|
3Y | $7.11 | -76.09% | -8.66% | -67.43 | 0 Comment |
RSS Headlines
Fool UK
- Active (2)
-
Ended (1)
-
All (3)
Results 1 - 2 of 2